Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey

BACKGROUND: During the current SARS‐CoV‐2 pandemic it is important to identify risk factors for COVID‐19. Registry studies are providing growing evidence on the elevated risk of mortality from COVID‐19 in patients with chronic liver disease, especially in advanced stages. Results may, however, have...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:United European Gastroenterol J
Asıl Yazarlar: Zecher, Britta Franziska, Buescher, Gustav, Willemse, José, Walmsley, Martine, Taylor, Alison, Leburgue, Angela, Schramm, Christoph, Lohse, Ansgar W., Sebode, Marcial
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Hepatobiliary
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242670/
https://ncbi.nlm.nih.gov/pubmed/34105883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ueg2.12100
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller